Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

Eligibility for treatment with the latest cancer drugs is often determined by genetic mutations in tumors, criteria that ...

The Head and Neck Radiation Oncology Group (GORTEC) announced significant improvement in disease-free survival for locally ...

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.

IGM Biosciences has halted all oncology programs and faces a significant pipeline upheaval. Read why I maintain my Sell ...

Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...

For women with newly diagnosed invasive breast cancer (BC), weight gain is associated with an increased risk for heart ...

UChicago Medicine Comprehensive Cancer Center has appointed Mitchell Posner, MD, as chief clinical officer. He will also serve as CCO for the health system's cancer service line.

Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

Mentor, mother, activist, advocate, sister, survivor, researcher and Fred Hutch friend, Bridgette Hempstead died last month ...